DENOVO-RBC

DENOVO-RBC

Project number: 641093
Funded under: H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)

Developing Novel and Optimal Additive Solutions for Red Blood Cells

Start date

End date

Status

1. March 2015

31. August 2016

Closed

Um verkefnið:

Total cost
EUR 150.000

Topic:
ERC-PoC-2014 - ERC Proof of Concept Grant

Total grant
EUR 150.000

Call for proposal:
ERC-2014-PoC

Coordinated by:
University of Iceland

Funding scheme:
ERC-POC - Proof of Concept Grant
 

More information about the project is here.

Objective

The research conducted in SYSTEM_US (ERC Advanced Grant #232816) has led to the discovery of valuable biomarkers for the quality of red blood cells (RBCs) in standard blood bank storage conditions. Using a combination of systems biology and metabolomics, this discovery will lead to the development of novel RBC storage technologies including additive solutions and diagnostics. These technologies will become valuable assets in the form of intellectual property to large transfusion medicine companies and will save thousands of lives over the coming decades. This proposal covers the needs to fully define the market and NPV of the developing technology, fully define the regulatory and clinical path of product approval, file for patents to protect the intellectual property, conduct necessary validation experiments, and continue to develop relations with industry contacts.

Coordinator

Háskóli Íslands (UoI)                                                  Iceland

Participants

Beneficiaries:

Háskóli Íslands

Iceland

 

 

Þú ert að nota: brimir.rhi.hi.is